-D J Mangelsdorf Researcher Activity Profile

Research Author Detailed Information 

D J Mangelsdorf Publication Rate By Year

D J Mangelsdorf has published 3 paper(s) in 2006, 14 paper(s) in 2007, 3 paper(s) in 2008, for a total of 20 research publications in total.

D J Dj Mangelsdorf Author Information

LAST NAME: mangelsdorf

FIRST NAME: D J

INITIALS: dj

AFFILIATION:

Papers

D J Mangelsdorf's Publication Record

1. Liver X receptors and cholesterol homoeostasis: spotlight on the adrenal gland. Year Published: 2006
Howard Hughes Medical Institute, Department of Pharmacology, University of Texas Southwestern Medical Center, 6001 Forest Park, Dallas, TX 75390-9050, USA. Carolyn.Cummins@UTSouthwestern.edu
2. Identification of a hormonal basis for gallbladder filling. Year Published: 2006
Department of Molecular Biology, University of Texas Southwestern Medical Center, 5323 Harry Hines Boulevard, Dallas, Texas 75390, USA.
3. Enzymatic reduction of oxysterols impairs LXR signaling in cultured cells and the livers of mice. Year Published: 2006
Department of Molecular Genetics, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
4. Functional interactions between the Moses corepressor and DHR78 nuclear receptor regulate growth in Drosophila. Year Published: 2007
Department of Human Genetics, University of Utah School of Medicine, Salt Lake City, Utah 84112, USA.
5. Activation of LXRs prevents bile acid toxicity and cholestasis in female mice. Year Published: 2007
Center for Pharmacogenetics and Department of Pharmaceutical Sciences, University of Pittsburgh, Pittsburgh, PA 15261, USA.
6. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Year Published: 2007
Department of Pharmacology and Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, 6001 Forest Park Road, Dallas, Texas 75390-9050, USA.
7. In vivo imaging of farnesoid X receptor activity reveals the ileum as the primary bile acid signaling tissue. Year Published: 2007
8. Endocrine Regulation of the Fasting Response by PPARalpha-Mediated Induction of Fibroblast Growth Factor 21. Year Published: 2007
Department of Molecular Biology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA.
9. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Year Published: 2007
Department of Pharmacology and Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, 6001 Forest Park Road, Dallas, Texas 75390-9050, USA.
10. Cardiac peroxisome proliferator-activated receptor gamma is essential in protecting cardiomyocytes from oxidative damage. Year Published: 2007
Cardiovascular Research Institute, Morehouse School of Medicine, 720 Westview Dr. SW, Atlanta, GA 30310, USA.
11. FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption. Year Published: 2007
Howard Hughes Medical Institute and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9050.
12. 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator. Year Published: 2007
Duke University Medical Center, Pharmacology and Cancer Biology, Box 3813, Durham, North Carolina 27710. donald.mcdonnell@duke.edu.
13. 27-Hydroxycholesterol is an endogenous SERM that inhibits the cardiovascular effects of estrogen. Year Published: 2007
Department of Pharmacology and Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, 6001 Forest Park Road, Dallas, Texas 75390-9050, USA.
14. Synthesis, characterization, and receptor interaction profiles of enantiomeric bile acids. Year Published: 2007
Department of Molecular Biology and Pharmacology, Washington University in St. Louis School of Medicine, 660 South Euclid Avenue, St. Louis, MO 63110, USA.
15. FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption. Year Published: 2007
Howard Hughes Medical Institute and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9050, USA.
16. High-throughput real-time quantitative reverse transcription PCR. Year Published: 2008
Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas.
17. High-throughput real-time quantitative reverse transcription PCR. Year Published: 2008
Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas, USA.
18. 27-hydroxycholesterol is an endogenous selective estrogen receptor modulator. Year Published: 2007
Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, North Carolina 27710, USA.
19. FXR agonists and FGF15 reduce fecal bile acid excretion in a mouse model of bile acid malabsorption. Year Published: 2007
Howard Hughes Medical Institute and Department of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX 75390-9050, USA.
20. High-throughput real-time quantitative reverse transcription PCR. Year Published: 2008
Howard Hughes Medical Institute, University of Texas Southwestern Medical Center, Dallas, Texas, USA.